In a report released yesterday, Srikripa Devarakonda from Truist Financial maintained a Buy rating on Nucana (NCNA – Research Report), with a price target of $20.00. The company’s shares ...

New research on a chemical substance from caterpillar fungus, known for its potential as a cancer treatment.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

EDINBURGH, United Kingdom, Sept. 25, 2024 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced the issuance of a new patent by the United States Patent and Trademark Office (USPTO) covering ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Gershell covers the Healthcare sector, focusing on stocks such as Capricor Therapeutics, Nucana, and Alnylam Pharma. According to TipRanks, Gershell has an average return of 2.8% and a 37.15% ...

European equities traded in the US as American depositary receipts started the week tracking higher late Monday morning, rising 0.49% to 1,366.51 on the S&P Europe Select ADR Index. From continental ...

At close: November 1 at 8:02 a.m. GMT+1 ...